PAR 3.77% 25.5¢ paradigm biopharmaceuticals limited..

Ann: Investor Presentation - $66m Capital Raise, page-24

  1. 2,128 Posts.
    lightbulb Created with Sketch. 569
    Very weak raise price - that's the issue.

    BP and PAR would be standing here saying "it was the right price, because that's where the SP is now" but i think that's the cart before the horse.

    If PAR says it $1.30 was fair price to do a $66M raise, then that's where it'll go.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.